Pathophysiology of myocardial infarction

A Skyschally, R Schulz, G Heusch - Herz, 2008 - search.proquest.com
One or several short cycles of ischemia/reperfusion before (preconditioning) or after
(postconditioning) a sustained coronary occlusion with subsequent reperfusion reduce the …

Application of medical gases in the field of neurobiology

W Liu, N Khatibi, A Sridharan, JH Zhang - Medical gas research, 2011 - Springer
Medical gases are pharmaceutical molecules which offer solutions to a wide array of
medical needs. This can range from use in burn and stroke victims to hypoxia therapy in …

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy

D Westermann, S Van Linthout, S Dhayat… - Basic research in …, 2007 - Springer
To investigate the effect of anti-cytokine-based therapy in the course of diabetic
cardiomyopathy, we performed a study using an anti-TNF-α monoclonal antibody treatment …

Sulfur dioxide preconditioning increases antioxidative capacity in rat with myocardial ischemia reperfusion (I/R) injury

H fang Jin, Y Wang, X bao Wang, Y Sun, C shu Tang… - Nitric oxide, 2013 - Elsevier
Background The study was designed to explore if sulfur dioxide (SO 2) preconditioning
increased antioxidative capacity in rat with myocardial ischemia reperfusion (I/R) injury …

Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia–reperfusion injury

P Lei, A Baysa, HI Nebb, G Valen, T Skomedal… - Basic research in …, 2013 - Springer
Liver X receptor (LXR)-α and-β play a major role in lipid and glucose homeostasis. Their
expression and function in the heart is not well characterized. Our aim was to describe the …

Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis

W Zhao, GC Fan, ZG Zhang, A Bandyopadhyay… - Basic research in …, 2009 - Springer
Peroxiredoxin II, a cytosolic isoform of the antioxidant enzyme family, has been implicated in
cancer-associated cell death and apoptosis, but its functional role in the heart remains to be …

Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart

X Wu, J Sagave, A Rutkovskiy, F Haugen, A Baysa… - Life sciences, 2014 - Elsevier
Aims Heart failure is associated with activation of fetal gene programs. Bone morphogenetic
proteins (BMPs) regulate embryonic development through interaction with BMP receptors …

Protein kinases as drug development targets for heart disease therapy

NS Dhalla, AL Müller - Pharmaceuticals, 2010 - mdpi.com
Protein kinases are intimately integrated in different signal transduction pathways for the
regulation of cardiac function in both health and disease. Protein kinase A (PKA), Ca2+ …

Gene therapy with hypoxia-inducible factor 1 alpha in skeletal muscle is cardioprotective in vivo

G Czibik, J Gravning, V Martinov, B Ishaq, E Knudsen… - Life sciences, 2011 - Elsevier
AIMS: Gene therapy of a peripheral organ to protect the heart is clinically attractive. The
transcription factor hypoxia-inducible factor 1 alpha (HIF-1α) transactivates cardioprotective …

Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2

A Doroszko, D Polewicz, J Sawicka… - Basic research in …, 2009 - Springer
The purpose of this study was to determine if decreased heart function after hypoxia
followed by reoxygenation (H–R) is associated with increased degradation of cardiac …